Symphogen A/S Announces The Appointment Of Annika Espander Jansson As Non-Executive Director
12/20/2013 6:37:27 AM
Symphogen A/S, a private biopharmaceutical company with leadership in recombinant antibody mixtures for therapeutic use, today announces the appointment of Annika Espander Jansson as a Non-Executive Director of the Board, with effect from 19 December 2013.
Annika has over twenty years’ experience in the healthcare sector, both as a sell-side analyst and investor. She has a proven track record in strategic development of businesses and broad experience in managing operations in different segments of the financial markets.
Help employers find you! Check out all the jobs and post your resume.
comments powered by